Category: SCIENCE

Scientific Journal: Cannabis’ “Schedule I Classification Is Not Tenable”

The present classification of cannabis and its organic compounds as schedule I prohibited substances under federal law is scientifically indefensible, according to a just published review in The Open Neurology Journal. Investigators with the University of California at San Diego and the University of California, Davis reviewed the results of several recent clinical trials assessing the safety and efficacy of inhaled or vaporized cannabis. They concluded: “Evidence is accumulating that cannabinoids may be useful medicine for certain indications. Control of nausea and vomiting and the promotion of weight gain in […]

Cannabis and Cannibalism: The Return Of Reefer Madness In The Media?

As I told staff this morning in an email, last night and this morning have been surreal being inundated with media requests for interviews on two totally disparate topics related to cannabis: -Chicago moving forward with cannabis decriminalization for possession -Media headlines (and some experts’ claims) that cannabis might have caused a guy to kill and chew his victim’s face off Talk about one topic being ‘good’, the other one being ‘bad’ (if not totally bizarre)! It is one thing for the media to report on the toxicological results from […]

Montana Republicans and Democrats Latest to Adopt Marijuana Reform Measures Into Platforms

Not to be outdone by the Democrats, whose state parties in Washington, Colorado, North Carolina, Texas, and Iowa have all recently adopted pro-reform policies in their platforms, the Montana Republican Party has endorsed medical marijuana at their state convention held on June 16th. The official language from their 2012 platform is as follows: Medical Use of Marijuana We recognize that a significant problem exists with Montana’s current laws regarding the medical use of marijuana and we support action by the next legislature to create a workable and realistic regulatory structure. […]

Study: Medical Marijuana Legalization Is Not Accompanied By Increases In Teen Cannabis Use

[Editor’s note: This post is excerpted from this week’s forthcoming NORML weekly media advisory. To have NORML’s news alerts and legislative advisories delivered straight to your in-box, sign up here.] The legalization of cannabis for therapeutic purposes is not associated with increases in the use of marijuana or other illicit substances among adolescents, according to discussion paper commissioned by the Institute for the Study of Labor (IZA) in Germany. Economists from Montana State University, the University of Oregon, and the University of Colorado, Denver examined the relationship between state medical […]

Study: Medical Cannabis Dispensaries Not Associated With Neighborhood Crime

The establishment of medical cannabis dispensaries does not adversely impact local crime rates, according to a federally funded study published in the Journal of Studies on Alcohol and Drugs. Investigators at the University of California, Los Angeles (UCLA) examined whether the proliferation of medical marijuana dispensaries is associated with elevated crimes rates. Researchers assessed the spatial relationship between density of medical marijuana dispensaries and two types of crime rates (violent crime and property crime) in 95 census tracts in Sacramento, California, during the year 2009. Researchers reported: “There were no […]

Study: Cannabis Use Associated With Lower Mortality Risk In Patients With Psychotic Disorders

[Editor’s note: This post is excerpted from this week’s forthcoming NORML weekly media advisory. To have NORML’s news alerts and legislative advisories delivered straight to your in-box, sign up here.] The use of cannabis is associated with lower mortality risk in patients with schizophrenia and related psychotic disorders, according to a forthcoming study to be published in the Journal of Psychiatric Research. (Read the abstract of the study online here.) An international team of investigators from the University of Maryland School of Medicine and Inje University in South Korea assessed […]

Marijuana and Autism Survey – NORML and UF4A Collaboration

Over the last five years there have been numerous media reports about the anecdotal use of cannabis to help autistic children. Two brave women, one on the east coast the other the west, have been at the forefront of this effort to help scientifically explain why cannabis appears to be so helpful. Marie Myung-Ok Lee wrote about her experience in Rhode Island, a state with medical cannabis laws, in 2009. Soon after, inspired by Marie’s writings, Mieko Perez Hester and her son had a similarly positive experience with treating his […]

Arizona Considering New Uses for Medical Marijuana

May 25, 2012 Dear NORML supporters in AZ, Good news! The Arizona Department of Health Services (azdhs.gov) who administers the medical cannabis program is apparently soliciting information on peer-reviewed research for the efficacious use of cannabis for four new conditions for consideration of including on the list of conditions acceptable for use under the official program. Those four conditions under consideration are: *Post traumatic stress disorder (PTSD) *Migraines *Depression *Generalized Anxiety Order The administrator, Will Humble, posted to the AZDHS blog on May 24th, 2012 that on “Friday afternoon” (May […]

American Universities: The Medical Cannabis Conundrum

Going back to at least 1998, NORML has been receiving complaints from parents and students that while the state where the university is located has legalized medical cannabis use and possession, because of the federal government’s recalcitrance and ‘flat earth’ view on cannabis’ medical utility, the student is threatened with sanctions or expulsion if they get caught with a lawful medicine. Seventeen states and the District of Columbia have legalized medical cannabis, more states are expected to soon join the cohort. The issue of medical cannabis on campus is a […]

Study: Non-Psychotropic Plant Cannabinoids Counteract Prostate Cancer Growth

[Editor’s note: This post is excerpted from this week’s forthcoming NORML weekly media advisory. To have NORML’s news alerts and legislative advisories delivered straight to your in-box, sign up here.] The administration of non-psychotropic plant cannabinoids, in particular cannabidiol (CBD), inhibit proliferation and selectively trigger cell suicide of prostate carcinoma, according to preclinical data to be published in the British Journal of Pharmacology. (Read the study abstract online here.) An international team of investigators from Italy and the United Kingdom assessed the anti-cancer properties of various non-psychoactive synthetic and botanical […]